Get the tools used by (smart)2 investors.

Long-term Debt for Ipca Laboratories Ltd.

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

IPCALAB: Ipca Laboratories Ltd.

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the A...

1,394.00 INR
Price
INR
Fair Value
Upside
1,052.00 - 1,755.90
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Ipca Laboratories Ltd.'s Long-term Debt:

Mar 2016Mar 2018Mar 2020Mar 2022Mar 20242 B4 B6 B

Performance Summary
  • Ipca Laboratories's long-term debt for fiscal years ending March 2020 to 2024 averaged 3.479 billion.
  • Ipca Laboratories's operated at median long-term debt of 3.952 billion from fiscal years ending March 2020 to 2024.
  • Looking back at the last 5 years, Ipca Laboratories's long-term debt peaked in March 2023 at 6.518 billion.
  • Ipca Laboratories's long-term debt hit its 5-year low in March 2021 of 91.3 million.
  • Ipca Laboratories's long-term debt decreased in 2020 (1.03 billion, -26.9%), 2021 (91.3 million, -91.1%), and 2024 (5.804 billion, -11.0%) and increased in 2022 (3.952 billion, +4,228.4%) and 2023 (6.518 billion, +64.9%).

How does Ipca Laboratories's Long-term Debt benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Ipca Laboratories Ltd. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Long-term Debt

Hide this widget
lt_debt
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Long-term Debt in the financials category include:

  • Interest on Long-Term Debt - This item represents the gross amount of interest on long-term debt.
  • Amortization of Deferred Charges (CF) - This item represents both amortization and write-off of deferred expenses. Deferred charges result from prepayment of expenses of capital nature (not represented by tangible assets) whose benefit, usually will extend over a period of years from the time of incurrence and so is carried forward for expenses in future years.
  • Current Portion of Total Debt - The sum of Short-term Borrowings, Current Portion of LT Debt and Capital Leases, Current due within the next year.
  • Total Debt Repaid - This item is the sum of following components: Capital Lease Payments, Trust Preferred Securities Repaid, Short Term Debt Repaid, and Long-Term Debt Repaid.
View Full List

Search for metric or datapoint

Long-term Debt

The sum of all long term debt fields.

Definition of Long-term Debt

Hide this widget

Ipca Laboratories did not report meaningful long-term debt for the latest quarter ending December 31, 2024 on its balance sheet.

The tables below summarizes Ipca Laboratories’s Long-term Debt and common size over the last five years:

Fiscal YearLong-term DebtAssets% Assets
2020-03-311.03 B52.598 B2.0%
2021-03-3191.3 M60.684 B0.2%
2022-03-313.952 B76.235 B5.2%
2023-03-316.518 B86.264 B7.6%
2024-03-315.804 B111 B5.2%

The tables below summarizes Ipca Laboratories’s Long-term Debt and common size over the last four quarters:

Quarter EndingLong-term DebtAssets% Assets
2024-03-315.804 B111 B5.2%
2024-06-30NANANA
2024-09-304.571 B114.2 B4.0%
2024-12-31NANANA

Click the link below to download a spreadsheet with an example Long-term Debt calculation for Ipca Laboratories Ltd. below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
2.302 B17.302 B32.302 B59.842 B020406080

The chart above depicts the distribution of long-term debt for companies operating in the Healthcare sector in the Developing economic region. Over 725 companies were considered in this analysis, and 700 had meaningful values. The average long-term debt of companies in the sector is 4.827 B with a standard deviation of 8.586 B.

Ipca Laboratories Ltd.'s Long-term Debt of - is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Long-term Debt In The Healthcare Sector
Economic Risk RegionDeveloping
Total Constituents730
Included Constituents700
Min2.681 M
Max59.061 B
Median1.207 B
Mean4.827 B
Standard Deviation8.586 B

You can find companies with similar long-term debt using this stock screener.

All rights reserved. Terms Of Use